Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bismuth citrate + carbomer
- Development stage
- Unknown
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Rectal
01
Overview
Bismuth citrate + carbomer is a pharmaceutical complex used primarily in rectal formulations for the treatment of inflammatory bowel conditions. It combines bismuth citrate, which possesses antimicrobial and cytoprotective properties, with carbomer (a polyacrylate polymer) that serves as a mucoadhesive agent to enhance local delivery and retention in the distal gastrointestinal tract. Bismuth compounds exert therapeutic effects through multiple mechanisms, including the disruption of bacterial cell walls, inhibition of enzymes such as urease, and the provision of a protective coating on the inflamed mucosa. This combination has been clinically evaluated for distal ulcerative colitis and chronic pouchitis, where it aims to reduce mucosal inflammation and bacterial load. In clinical trials, it has demonstrated efficacy comparable to standard treatments like 5-aminosalicylic acid (5-ASA) without evidence of systemic bismuth accumulation.
- Other names
- bismuth carbomerbismuth citrate-carbomerbismuth citrate-polyacrylate complex
02
Targets
Urease
Beyond the preview
Go deeper on bismuth citrate + carbomer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bismuth citrate + carbomer.